Mergers & Acquisitions Mergers & Acquisitions

EssilorLuxottica’s GrandVision remedies in EU fall short of opticians’ expectations

By Andrew Boyce
  • 26 Feb 2021 05:30
  • 26 Feb 2021 05:30

EssilorLuxottica’s offer to address EU concerns about its buyout of GrandVision doesn’t do the trick for independent opticians, who have recently been asked to comment on a revised set of remedy proposals, MLex has learned.

Some of the strongest opposition to the proposal is in Italy, where the national opticians associa

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Andrew Boyce

Correspondent


Andrew is a reporter covering merger reviews and competition policy for MLex in Brussels. He joined MLex in 2015 and holds a degree and a master’s degree in history from the University of Liverpool.

Discover MLex

Stay on top of global regulatory developments

Latest News